Baker Ellis Asset Management LLC
Position in BMY — Bristol Myers Squibb Co
CIK 1365559
Vancouver, WA
Position in BMY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$256,409
-$13,483 QoQ
Shares Held
4,450
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,976
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baker Ellis Asset Management LLC holds $17,156,761 across 7 Drug Manufacturers - General names. BMY ranks #7 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,547 | $4,254,378 | |
| 2 | SNY |
Sanofi
|
81,342 | $3,470,049 | |
| 3 | JNJ |
Johnson & Johnson
|
13,294 | $3,376,277 | |
| 4 | NVS |
Novartis AG
|
14,950 | $2,342,964 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,988 | $1,925,958 | |
| 6 | ABBV |
AbbVie Inc.
|
6,083 | $1,530,726 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
4,450 | $256,409 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $256,409 | 4,450 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $269,892 | 4,450 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $244,348 | 4,530 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $231,363 | 5,130 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $242,096 | 5,230 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $349,472 | 5,730 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $324,088 | 5,730 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $301,644 | 5,830 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $246,272 | 5,930 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $332,429 | 6,130 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $335,054 | 6,530 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $454,453 | 7,830 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $517,739 | 8,096 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $561,133 | 8,096 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $618,985 | 8,603 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $611,587 | 8,603 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $631,631 | 8,203 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $562,038 | 7,696 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $479,845 | 7,696 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $455,372 | 7,696 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $537,633 | 8,046 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $486,858 | 7,712 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $519,687 | 8,378 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $496,307 | 8,232 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $501,799 | 8,534 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $488,951 | 8,772 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||